Nemaura Medical Inc. (NASDAQ: NMRD) Offers ‘First-of-a-Kind’ Device in Growing CGM Market
The global continuous glucose monitoring devices market size is expected to reach $19.04 billion in 2028The increasing prevalence of diabetes, rising focus on preventive care are significant factors in the steady revenue growthNemaura Medical’s sugarBEAT device allows individuals to make adjustments to diet and activity that can significantly change their lives According to a recent Reports and Data release, the global consumer monitoring (“CGM”) devices global market…